Plasma sphingosine 1-phosphate concentrations and cardiovascular autonomic neuropathy in individuals with type 2 diabetes
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-69566-y
Abstract: The aim of this study was to test the hypothesis that plasma sphingosine 1-phosphate (S1P) levels are associated with the risk of cardiovascular autonomic neuropathy (CAN) in type 2 diabetes patients. This cross-sectional study included… read more here.
Keywords: plasma s1p; type diabetes; plasma sphingosine; s1p levels ... See more keywords
1881-LB: Association of Plasma Sphingosine and Sphingomyelin with Incident Diabetes in the Diabetes Prevention Program (DPP) and Outcomes Study (DPPOS)
Sign Up to like & getrecommendations! Published in 2025 at "Diabetes"
DOI: 10.2337/db25-1881-lb
Abstract: Introduction and Objective: Sphingomyelin (SM) and sphingosine (SO) species have been associated with diabetes risk. We assessed plasma SM and SO levels in relation to incident type 2 diabetes (T2D) in the DPP/DPPOS. Methods: Adults… read more here.
Keywords: sphingosine; plasma sphingosine; none; dpp ... See more keywords